Retatrutide is currently only accessible through clinical trials
Orforglipron is a non-peptide oral GLP-1 medication
Researchers developed longer-lasting versions: liraglutide, then semaglutide and tirzepatide the compounds behind todays headline-making medications
It supports the machinery that burns fat for energy, but the weight itself still comes off through calories, satiety, and a plan you can keep not through the supplement alone
[DOI] [PMC free article] [PubMed] [Google Scholar] 156.Bourbour M., Khayam N., Noorbazargan H., Tavakkoli Yaraki M., Asghari Lalami Z., Akbarzadeh I., Eshrati Yeganeh F., Dolatabadi A., Mirzaei Rad F., Tan Y.N